首页 > 最新文献

Mayo Clinic proceedings最新文献

英文 中文
Lipoprotein(a): Moving Beyond Recognition to Intervention. 脂蛋白(a):从认识到干预。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-05 DOI: 10.1016/j.mayocp.2025.12.009
Shaun Khanna, Nitesh Nerlekar, Aditya Bhat
{"title":"Lipoprotein(a): Moving Beyond Recognition to Intervention.","authors":"Shaun Khanna, Nitesh Nerlekar, Aditya Bhat","doi":"10.1016/j.mayocp.2025.12.009","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.12.009","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146125643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of Patient Self-Reported Menopause Stage: A Cross-Sectional Study. 患者自我报告绝经期的准确性:一项横断面研究。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-04 DOI: 10.1016/j.mayocp.2025.11.013
Nancy Safwan, Jana Karam, Rickey E Carter, Rajeev Chaudhry, Ekta Kapoor, Juliana M Kling, Kristin Cole, Stacey J Winham, Chrisandra L Shufelt, Stephanie S Faubion

Objective: To evaluate the accuracy of patient self-reported menopause stage among midlife US women.

Patients and methods: This cross-sectional analysis included women 40 to 65 years of age who presented to women's health clinics at one of three Mayo Clinic sites from December 2016 to September 2019. Patients self-reported their menopause stage (pre-, peri-, postmenopausal, or unsure) while clinician-determined stage (pre-, peri-, postmenopausal, or unknown) was assessed by menopause-trained specialists using a standardized form. Only women with both self- and clinician-reported menopause stages were included.

Results: A total of 3411 women (mean age 53.5±6.2 years) were included with the majority being White (91.1%), educated (67.2%, at least some college education) and married/partnered (84.1%). Overall, 323 (9.5%), 640 (18.8%), 1182 (34.7%), and 1266 (37.1%) women self-reported being pre-, peri, postmenopausal, or unsure, respectively. Patient-reported and clinician-determined menopause stages aligned in only 56.6% of cases (n=1930, kappa=0.38). Notably, more than one-third of women (n=1266, 37.1%) reported being unsure of their menopause stage, whereas just 389 (11.4%) were classified as unknown by their clinicians. Of those who self-reported being unsure of their stage, 958 (75.7%) were classified as postmenopausal by clinicians. In a subset of women from 45 to 55 years of age (n=1786), the agreement was 56.8% (n=1015, kappa=0.40), with the highest concordance observed in the postmenopausal stage (41.0%).

Conclusion: These findings highlight significant discrepancies between patient-reported and clinician-determined menopause stages, underscoring a lack of awareness among women regarding their menopause stage. This gap may result in missed opportunities for timely and appropriate interventions for care.

目的:评价美国中年妇女自我报告绝经期的准确性。患者和方法:这项横断面分析包括了2016年12月至2019年9月期间在梅奥诊所三个地点之一的女性健康诊所就诊的40至65岁的女性。患者自我报告其绝经期(绝经前、绝经前后、绝经后或不确定),而临床确定的绝经期(绝经前、绝经前后、绝经后或未知)由经绝经培训的专家使用标准化表格进行评估。仅包括自我和临床报告的绝经期妇女。结果:共纳入3411名女性(平均年龄53.5±6.2岁),其中白人(91.1%)、受过教育(67.2%,大专以上)、已婚/有伴侣(84.1%)居多。总体而言,分别有323名(9.5%)、640名(18.8%)、1182名(34.7%)和1266名(37.1%)女性自我报告为绝经前、围绝经期、绝经后或不确定。只有56.6%的病例(n=1930, kappa=0.38)患者报告和临床确定的绝经期相一致。值得注意的是,超过三分之一的女性(n=1266, 37.1%)报告不确定她们的绝经期,而只有389(11.4%)被临床医生归类为未知。在那些自我报告不确定其阶段的人中,958人(75.7%)被临床医生归类为绝经后。在45岁至55岁的女性(n=1786)中,一致性为56.8% (n=1015, kappa=0.40),在绝经后阶段观察到最高的一致性(41.0%)。结论:这些发现强调了患者报告和临床确定的更年期阶段之间的显著差异,强调了女性对更年期阶段缺乏认识。这一差距可能导致错失及时和适当的护理干预措施的机会。
{"title":"Accuracy of Patient Self-Reported Menopause Stage: A Cross-Sectional Study.","authors":"Nancy Safwan, Jana Karam, Rickey E Carter, Rajeev Chaudhry, Ekta Kapoor, Juliana M Kling, Kristin Cole, Stacey J Winham, Chrisandra L Shufelt, Stephanie S Faubion","doi":"10.1016/j.mayocp.2025.11.013","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.11.013","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the accuracy of patient self-reported menopause stage among midlife US women.</p><p><strong>Patients and methods: </strong>This cross-sectional analysis included women 40 to 65 years of age who presented to women's health clinics at one of three Mayo Clinic sites from December 2016 to September 2019. Patients self-reported their menopause stage (pre-, peri-, postmenopausal, or unsure) while clinician-determined stage (pre-, peri-, postmenopausal, or unknown) was assessed by menopause-trained specialists using a standardized form. Only women with both self- and clinician-reported menopause stages were included.</p><p><strong>Results: </strong>A total of 3411 women (mean age 53.5±6.2 years) were included with the majority being White (91.1%), educated (67.2%, at least some college education) and married/partnered (84.1%). Overall, 323 (9.5%), 640 (18.8%), 1182 (34.7%), and 1266 (37.1%) women self-reported being pre-, peri, postmenopausal, or unsure, respectively. Patient-reported and clinician-determined menopause stages aligned in only 56.6% of cases (n=1930, kappa=0.38). Notably, more than one-third of women (n=1266, 37.1%) reported being unsure of their menopause stage, whereas just 389 (11.4%) were classified as unknown by their clinicians. Of those who self-reported being unsure of their stage, 958 (75.7%) were classified as postmenopausal by clinicians. In a subset of women from 45 to 55 years of age (n=1786), the agreement was 56.8% (n=1015, kappa=0.40), with the highest concordance observed in the postmenopausal stage (41.0%).</p><p><strong>Conclusion: </strong>These findings highlight significant discrepancies between patient-reported and clinician-determined menopause stages, underscoring a lack of awareness among women regarding their menopause stage. This gap may result in missed opportunities for timely and appropriate interventions for care.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146125574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary Hyperparathyroidism in Patients After Roux-en-Y Gastric Bypass Surgery: A Case Series. Roux-en-Y胃旁路手术后继发性甲状旁腺功能亢进:一个病例系列。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-04 DOI: 10.1016/j.mayocp.2025.12.015
Lena Ayari, Leidy Plaza-Enriquez, Daniel L Hurley
{"title":"Secondary Hyperparathyroidism in Patients After Roux-en-Y Gastric Bypass Surgery: A Case Series.","authors":"Lena Ayari, Leidy Plaza-Enriquez, Daniel L Hurley","doi":"10.1016/j.mayocp.2025.12.015","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.12.015","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146125589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoglobulin Light Chain Amyloidosis. 免疫球蛋白轻链淀粉样变。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-03 DOI: 10.1016/j.mayocp.2025.08.016
Mahin Bhatt, Dragan Jevremovic, S Vincent Rajkumar
{"title":"Immunoglobulin Light Chain Amyloidosis.","authors":"Mahin Bhatt, Dragan Jevremovic, S Vincent Rajkumar","doi":"10.1016/j.mayocp.2025.08.016","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.08.016","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship of Digestible Carbohydrate Intake Level and Cardiovascular Disease and Type 2 Diabetes: A Systematic Review and Meta-analysis. 可消化碳水化合物摄入水平与心血管疾病和2型糖尿病的关系:一项系统综述和荟萃分析
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-02 DOI: 10.1016/j.mayocp.2025.09.022
Zhen Wang, Alaa Al Nofal, Meera Shah, Sara L Bonnes, Samer Saadi, Alzhraa S Abbas, Magdoleen H Farah, Tarek Nayfeh, Kelly E Viola, Mohammed Firwana, Farah Fleti, Zin Tarakji, Larry J Prokop, M Hassan Murad

Objectives: To evaluate the association between the dietary digestible carbohydrate intake level and the incidence of cardiovascular disease (CVD) and type 2 diabetes (T2D).

Methods: We searched Embase, MEDLINE, and Cochrane Central from January 1, 2000, to July 19, 2024, to find randomized controlled trials and prospective cohort studies evaluating healthy individuals over 2 years of age, isolating for the effect of the digestible carbohydrate intake level from other macronutrients.

Results: Thirty prospective cohort studies with more than 1.7 million participants were included. Most of the studies reported inadequate confounding adjustment and were deemed to have serious risks of bias. No eligible studies evaluated children under 18 years. The association between the digestible carbohydrate intake level and CVD and T2D was nonlinear, which was supported by a low strength of evidence. The risk of CVD was the lowest at a carbohydrate intake level of 50% of total energy intake. The risk of CVD significantly increased when the carbohydrate intake level exceeded 65% of total energy intake. The risk of incident T2D gradually reduced with increasing carbohydrate intake levels up to 45% of total energy intake, then plateaued between 45% and 55% of total energy intake, before rising with higher carbohydrate intake levels. The nonlinear relationships were overall similar based on sex or geographic location but with variable intake range associated with the lowest risk.

Conclusion: A U-shaped relationship was observed between the intake level of digestible carbohydrates and CVD and T2D. The findings have important implications on the incidence and morbidity of chronic conditions and public health.

Registration: clinicaltrials.gov: PROSPERO #CRD42024494567 and CRD42024496101.

目的:探讨膳食可消化碳水化合物摄入水平与心血管疾病(CVD)和2型糖尿病(T2D)发病率的关系。方法:从2000年1月1日至2024年7月19日,我们检索了Embase、MEDLINE和Cochrane Central,以找到评估2岁以上健康个体的随机对照试验和前瞻性队列研究,将可消化碳水化合物摄入水平与其他宏量营养素的影响分离出来。结果:纳入了30项前瞻性队列研究,参与者超过170万。大多数研究报告混杂校正不足,被认为有严重的偏倚风险。没有符合条件的研究评估了18岁以下的儿童。可消化碳水化合物摄入量与CVD和T2D之间的关系是非线性的,证据强度较低。当碳水化合物摄入量为总能量摄入的50%时,心血管疾病的风险最低。当碳水化合物摄入量超过总能量摄入量的65%时,心血管疾病的风险显著增加。当碳水化合物摄入量占总能量摄入量的45%时,发生T2D的风险逐渐降低,然后在总能量摄入量的45%至55%之间趋于稳定,然后随着碳水化合物摄入量的增加而上升。基于性别或地理位置的非线性关系总体上相似,但不同的摄入范围与最低风险相关。结论:可消化碳水化合物摄入量与CVD、T2D呈u型关系。这些发现对慢性病的发病率和发病率以及公共卫生具有重要意义。注册:clinicaltrials.gov: PROSPERO #CRD42024494567和CRD42024496101。
{"title":"The Relationship of Digestible Carbohydrate Intake Level and Cardiovascular Disease and Type 2 Diabetes: A Systematic Review and Meta-analysis.","authors":"Zhen Wang, Alaa Al Nofal, Meera Shah, Sara L Bonnes, Samer Saadi, Alzhraa S Abbas, Magdoleen H Farah, Tarek Nayfeh, Kelly E Viola, Mohammed Firwana, Farah Fleti, Zin Tarakji, Larry J Prokop, M Hassan Murad","doi":"10.1016/j.mayocp.2025.09.022","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.09.022","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the association between the dietary digestible carbohydrate intake level and the incidence of cardiovascular disease (CVD) and type 2 diabetes (T2D).</p><p><strong>Methods: </strong>We searched Embase, MEDLINE, and Cochrane Central from January 1, 2000, to July 19, 2024, to find randomized controlled trials and prospective cohort studies evaluating healthy individuals over 2 years of age, isolating for the effect of the digestible carbohydrate intake level from other macronutrients.</p><p><strong>Results: </strong>Thirty prospective cohort studies with more than 1.7 million participants were included. Most of the studies reported inadequate confounding adjustment and were deemed to have serious risks of bias. No eligible studies evaluated children under 18 years. The association between the digestible carbohydrate intake level and CVD and T2D was nonlinear, which was supported by a low strength of evidence. The risk of CVD was the lowest at a carbohydrate intake level of 50% of total energy intake. The risk of CVD significantly increased when the carbohydrate intake level exceeded 65% of total energy intake. The risk of incident T2D gradually reduced with increasing carbohydrate intake levels up to 45% of total energy intake, then plateaued between 45% and 55% of total energy intake, before rising with higher carbohydrate intake levels. The nonlinear relationships were overall similar based on sex or geographic location but with variable intake range associated with the lowest risk.</p><p><strong>Conclusion: </strong>A U-shaped relationship was observed between the intake level of digestible carbohydrates and CVD and T2D. The findings have important implications on the incidence and morbidity of chronic conditions and public health.</p><p><strong>Registration: </strong>clinicaltrials.gov: PROSPERO #CRD42024494567 and CRD42024496101.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuning in To Recovery: Music's Role in Pain Reduction After Cardiothoracic Surgery. 调整到恢复:音乐在心肺手术后减轻疼痛中的作用。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-02 DOI: 10.1016/j.mayocp.2025.11.009
Lindsey P Trinchet, Kai Yuan Chen, Andrea A Lopez-Ruiz, Denise M Millstine, Lopa Misra

Cardiothoracic surgery can be a physically and emotionally challenging experience for patients, often involving significant pain, anxiety, and a reliance on opioid-based analgesia. As health care moves toward more holistic and patient-centered approaches, there is growing interest in complementary therapies like music. Music interventions represent a safe, noninvasive, and cost-effective strategy to support recovery in cardiothoracic surgery patients. This review explores how music interventions can support recovery in patients undergoing cardiothoracic procedures, focusing on pain reduction, anxiety alleviation, and physiological responses. A search of PubMed, CINAHL, and PsychInfo identified 19 studies, primarily randomized controlled trials, investigating music interventions during the perioperative period in adult cardiothoracic surgery patients. Across the studies reviewed, music interventions significantly reduced postoperative pain and anxiety compared with control groups. Several trials also reported reductions in analgesic use, heart rate, and blood pressure, although findings on physiological measures were mixed. Although further research is still warranted to optimize implementation and assess long-term benefits, the current evidence suggests that music can positively impact surgical recovery. Incorporating music into multimodal recovery protocols may improve patient experiences and reduce reliance on pharmacological interventions.

对于患者来说,心胸外科手术可能是一种身体和情感上的挑战,通常涉及明显的疼痛、焦虑和对阿片类药物镇痛的依赖。随着医疗保健朝着更全面、更以病人为中心的方向发展,人们对音乐等补充疗法的兴趣越来越大。音乐干预是一种安全、无创、经济有效的策略,可支持心胸外科患者的康复。这篇综述探讨了音乐干预如何支持接受心胸手术的患者的康复,重点是减轻疼痛,减轻焦虑和生理反应。PubMed、CINAHL和PsychInfo检索了19项研究,主要是随机对照试验,调查了成人心胸外科手术患者围手术期音乐干预的效果。在回顾的研究中,与对照组相比,音乐干预显著减少了术后疼痛和焦虑。几项试验也报告了镇痛药使用、心率和血压的减少,尽管生理测量的结果好坏参半。虽然进一步的研究仍需要优化实施和评估长期效益,但目前的证据表明,音乐对手术恢复有积极的影响。将音乐纳入多模式康复方案可以改善患者体验并减少对药物干预的依赖。
{"title":"Tuning in To Recovery: Music's Role in Pain Reduction After Cardiothoracic Surgery.","authors":"Lindsey P Trinchet, Kai Yuan Chen, Andrea A Lopez-Ruiz, Denise M Millstine, Lopa Misra","doi":"10.1016/j.mayocp.2025.11.009","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.11.009","url":null,"abstract":"<p><p>Cardiothoracic surgery can be a physically and emotionally challenging experience for patients, often involving significant pain, anxiety, and a reliance on opioid-based analgesia. As health care moves toward more holistic and patient-centered approaches, there is growing interest in complementary therapies like music. Music interventions represent a safe, noninvasive, and cost-effective strategy to support recovery in cardiothoracic surgery patients. This review explores how music interventions can support recovery in patients undergoing cardiothoracic procedures, focusing on pain reduction, anxiety alleviation, and physiological responses. A search of PubMed, CINAHL, and PsychInfo identified 19 studies, primarily randomized controlled trials, investigating music interventions during the perioperative period in adult cardiothoracic surgery patients. Across the studies reviewed, music interventions significantly reduced postoperative pain and anxiety compared with control groups. Several trials also reported reductions in analgesic use, heart rate, and blood pressure, although findings on physiological measures were mixed. Although further research is still warranted to optimize implementation and assess long-term benefits, the current evidence suggests that music can positively impact surgical recovery. Incorporating music into multimodal recovery protocols may improve patient experiences and reduce reliance on pharmacological interventions.</p>","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital Absolute Neutrophil Count Reference Intervals and Specificity of the Population Served. 医院绝对中性粒细胞计数参考区间和服务人群的特异性。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-02 DOI: 10.1016/j.mayocp.2024.12.015
Lucas T Go, Lewis T Go, Madugodaralalage D S K Gunaratne, Grant M Spears, Jithma P Abeykoon
{"title":"Hospital Absolute Neutrophil Count Reference Intervals and Specificity of the Population Served.","authors":"Lucas T Go, Lewis T Go, Madugodaralalage D S K Gunaratne, Grant M Spears, Jithma P Abeykoon","doi":"10.1016/j.mayocp.2024.12.015","DOIUrl":"https://doi.org/10.1016/j.mayocp.2024.12.015","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design and Development of a Medical Illustration Elective to Enhance Medical Student Learning and Wellness. 设计和开发医学插图选修课,以提高医学生的学习和健康。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-02 DOI: 10.1016/j.mayocp.2025.12.008
Krishna Sinha, Annika N Hiredesai, Stephen P Graepel, Sarah E Faris, Emilyn P Frohn, Frank M Corl, Kathleen J Van Buren
{"title":"Design and Development of a Medical Illustration Elective to Enhance Medical Student Learning and Wellness.","authors":"Krishna Sinha, Annika N Hiredesai, Stephen P Graepel, Sarah E Faris, Emilyn P Frohn, Frank M Corl, Kathleen J Van Buren","doi":"10.1016/j.mayocp.2025.12.008","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.12.008","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of Ferric Carboxymaltose in Heart Failure Patients With Iron Deficiency Across Ferritin Levels, Heart Failure Causes, and Prior Hospitalization Status: A Meta-Analysis. 羧基麦芽糖铁治疗缺铁性心力衰竭患者的安全性:一项meta分析,涉及铁蛋白水平、心力衰竭原因和先前住院情况。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-02 DOI: 10.1016/j.mayocp.2025.12.006
Ahmed Elbataa, Ahmed Hamdy G Ali, Ahmed Mansour, Ahmed Elazab, Hossam Elbenawi, Ahmed Abdelaziz, Basel Abdelazeem, Carl J Lavie
{"title":"Safety of Ferric Carboxymaltose in Heart Failure Patients With Iron Deficiency Across Ferritin Levels, Heart Failure Causes, and Prior Hospitalization Status: A Meta-Analysis.","authors":"Ahmed Elbataa, Ahmed Hamdy G Ali, Ahmed Mansour, Ahmed Elazab, Hossam Elbenawi, Ahmed Abdelaziz, Basel Abdelazeem, Carl J Lavie","doi":"10.1016/j.mayocp.2025.12.006","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.12.006","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brief Report: Sodium-Glucose Cotransporter Inhibitors and Clinical Outcomes in Hypertrophic Cardiomyopathy, A Retrospective Cohort Study. 摘要:钠-葡萄糖共转运蛋白抑制剂和肥厚性心肌病的临床结果,一项回顾性队列研究。
IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-02 DOI: 10.1016/j.mayocp.2025.12.014
Amro Badr, Mustafa Suppah, Kamal Awad, Mohammed Tiseer Abbas, Humam Abo Abdullah, Reza Arsanjani, Chadi Ayoub, Said Alsidawi
{"title":"Brief Report: Sodium-Glucose Cotransporter Inhibitors and Clinical Outcomes in Hypertrophic Cardiomyopathy, A Retrospective Cohort Study.","authors":"Amro Badr, Mustafa Suppah, Kamal Awad, Mohammed Tiseer Abbas, Humam Abo Abdullah, Reza Arsanjani, Chadi Ayoub, Said Alsidawi","doi":"10.1016/j.mayocp.2025.12.014","DOIUrl":"https://doi.org/10.1016/j.mayocp.2025.12.014","url":null,"abstract":"","PeriodicalId":18334,"journal":{"name":"Mayo Clinic proceedings","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mayo Clinic proceedings
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1